C-kit Expression in Oral Leukoplakia

被引:0
作者
Tegginamani, Anand S. [1 ]
Shivakumar, Vanishree H. [1 ]
Ismail, Siti Mazlipah B. [2 ]
Abraham, Mannil T. [3 ]
Fernandes, Bennete A. [1 ]
Zamzuri, Ahmad Termizi B. [1 ]
机构
[1] SEGi Univ, Fac Dent, Petaling Jaya, Selangor, Malaysia
[2] Univ Malaya, Fac Dent, Kuala Lumpur, Malaysia
[3] Sentosa Specialist Hosp, Dept Dent, Klang, Selangor, Malaysia
来源
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN | 2022年 / 32卷 / 02期
关键词
CD; 117; Disease progression; Oral dysplasia; Oral leukoplakia; Risk prediction; CD117;
D O I
10.29271/jcpsp.2022.02.256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Oral leukoplakia is the most common potentially malignant oral disorder. Oral leukoplakia's malignant potential is independent of the histopathological grade, and the malignant transformation rate varies greatly from 3% to 50% even in the case of severe epithelial dysplasia. Ethnic & environmental variables may contribute to this variation. C-kit immunohistochemistry was performed on 15 oral leukoplakia (OL), two oral squamous cell carcinoma (OSCC), and two dentigerous cysts (DC). The objective of this study was to evaluate the c-kit expression in oral leukoplakia. The use of various immunohistochemical markers to differentiate between OLs with a high and low risk of malignant transformation has been investigated. Only four OL exhibited a faint cytoplasmic expression in basal cells. Whereas, OSCC and DC were devoid of c-kit expression. Thus, this may not be a unique marker for identifying OL at high-risk. Further research with larger sample size is required.
引用
收藏
页码:256 / 258
页数:3
相关论文
共 6 条
  • [1] Differential expression of c-kit and CD43 in histological subtypes of adenoid cystic carcinoma of salivary gland
    Ahmed, Mohamed M.
    Abo-Hager, Eman A.
    [J]. SAUDI DENTAL JOURNAL, 2010, 22 (01) : 27 - 34
  • [2] CD117 (KIT) is a useful immunohistochemical marker for differentiating porocarcinoma from squamous cell carcinoma
    Goto, Keisuke
    Takai, Toshihiro
    Fukumoto, Takaya
    Anan, Takashi
    Kimura, Tetsunori
    Ansai, Shin-ichi
    Oshitani, Yoshimi
    Murata, Yozo
    Sakuma, Toshiko
    Hirose, Takanori
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2016, 43 (03) : 219 - 226
  • [3] Margaritescu C, 2011, ROM J MORPHOL EMBRYO, V52, P985
  • [4] Expression of protein tyrosine kinases in head and neck squamous cell carcinomas
    Ongkeko, WM
    Altuna, X
    Weisman, RA
    Wang-Rodriguez, J
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2005, 124 (01) : 71 - 76
  • [5] Sathiyamoorthy J, 2018, ASIAN J PHARM CLIN R, V11, P247
  • [6] Oral potentially malignant disorders: risk of progression to malignancy
    Speight, Paul M.
    Khurram, Syed Ali
    Kujan, Omar
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2018, 125 (06): : 612 - 627